SCHEMBL13998036

SCHEMBL13998036

CC(=O)C1=COC(O)[C@H]2[C@@H]1[C@H](O)[C@H](O)[C@]2(C)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14010694 0.73 POLB (0.39) —
SCHEMBL13998090 0.72 PTPN1 (0.41) —
SCHEMBL13998040 0.71 PTPN1 (0.40) —
SCHEMBL13998091 0.67 PTPN1 (0.39) —
SCHEMBL13998038 0.65 POLB (0.36) —
SCHEMBL28252239 0.64 PTPN1 (0.41) —
SCHEMBL13998196 0.61 PTPN1 (0.53) —
SCHEMBL10042322 0.58 HSP90AA1 (0.30) —
SCHEMBL7856180 0.52 CA1 (0.35) —
SCHEMBL7912952 0.52 CA1 (0.35) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080319042-A1 Compositions and methods for treatment of liver disease CALECO PHARMA CORP. 2008-12-25 — — US disclosed
Send feedback